Reducing mortality from 2019-nCoV: host-directed therapies should be an option - Zumla, Alimuddin; Hui, David S; Azhar, Esam I; Memish, Ziad A; Maeurer, Markus (The Lancet (British edition), 2020)
Keywords: Betacoronavirus; Colony-stimulating factor; Coronavirus Infections - drug therapy; Coronavirus Infections - mortality; Coronavirus Infections - therapy; Coronaviruses; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Cytokines; Disease transmission; Drug Discovery; Fibrosis; Global Health; Humans; Immune response; Immunization, Passive; Immunosuppressive agents; Infections; Inflammation; Intensive care; Interferon; Interleukin 17; Leukocytes (granulocytic); Lungs; Lymphocytes T; Macrophage inflammatory protein; Macrophage inflammatory protein 1; Monocyte chemoattractant protein; Monocyte chemoattractant protein 1; Monocytes; Pandemics; Patients; Pneumonia, Viral - therapy; Proteins; Quality of life; Respiratory distress syndrome; SARS-CoV-2; Sepsis; Tumor necrosis factor; Tumors; γ-Interferon